BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SVACS - ECPv6.15.1.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.siliconvalleyacs.org
X-WR-CALDESC:Events for SVACS
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20231116T100000
DTEND;TZID=America/Los_Angeles:20231116T110000
DTSTAMP:20260603T193238
CREATED:20231103T224535Z
LAST-MODIFIED:20231103T224755Z
UID:20382-1700128800-1700132400@www.siliconvalleyacs.org
SUMMARY:Antibody-drug conjugates: Using IP and R&D Trends to Inform Innovation
DESCRIPTION:Sponsored by CAS (Chemical Abstracts Service)\n10:00-11:00am\, Online via Zoom\, Free\, Registration required\n\nAntibody-drug conjugates (ADCs) are among the most promising drug classes in oncology. The ADC research landscape is rapidly evolving\, driven by advancements in antibody engineering\, linker technology\, payload development and diversification\, and more. These new innovations are reshaping the promise of ADCs.. However\, they also present challenges for innovators and drug developers seeking to understand the complex and competitive intellectual property (IP) landscape. \nIn this webinar\, experts will explore the latest trends in ADC innovation and the complications of understanding the IP landscape in this area. They will highlight the critical importance of staying up to date with evolving R&D trends and patent filings to determine freedom to operate\, protect complex innovations\, and maximize ROI. \nWhat you will learn\n\n\nThe evolving global research and IP landscape of antibody-drug conjugates.\nUnique challenges of developing ADC therapeutics.\nThe competitive landscape and complex patent claims for related technologies.\nStrategies for a comprehensive IP search to inform investment and protect your innovations.\nInsights into how CAS content and solutions can enable innovators and IP professionals.
URL:https://www.siliconvalleyacs.org/event/antibody-drug-conjugates-using-ip-and-rd-trends-to-inform-innovation/
LOCATION:Virtual
CATEGORIES:CAS Webinar
ATTACH;FMTTYPE=image/png:https://www.siliconvalleyacs.org/wp-content/uploads/2023/11/Antibody-Drug-Conjugates.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20231129T070000
DTEND;TZID=America/Los_Angeles:20231129T080000
DTSTAMP:20260603T193238
CREATED:20231103T225950Z
LAST-MODIFIED:20231103T225950Z
UID:20385-1701241200-1701244800@www.siliconvalleyacs.org
SUMMARY:Making dark formulations data work for you
DESCRIPTION:Sponsored by CAS (Chemical Abstracts Service)\n7:00-8:00am\, Online via Zoom\, Free\, Registration required\n\nJoin us for a discussion on formulations data with panelists from CAS\, Dow\, and Procter & Gamble. Learn about the challenges and opportunities of digitizing and leveraging formulations data to uncover valuable insights and enhance your company’s formulation innovation. \n\n\n\nWhat you will learn\n\n\nThe pitfalls of digitization and how to overcome them\nBest practices to search\, retrieve\, analyze\, and connect your data\nStrategies for getting the most from your existing data\, adding value and enhancing innovation
URL:https://www.siliconvalleyacs.org/event/making-dark-formulations-data-work-for-you/
LOCATION:Virtual
CATEGORIES:CAS Webinar
ATTACH;FMTTYPE=image/png:https://www.siliconvalleyacs.org/wp-content/uploads/2023/11/Making-Dark-Formulations-Data-Work-for-You.png
END:VEVENT
END:VCALENDAR